The Conundrum of Dual Primary Malignancies: Four Years’ Experience of a Single Tertiary Care Institute in India

Abstract

Background: Encountering more than one malignancy in a cancer patient is no longer uncommon; this increasing incidence is mostly attributable to the improvements in life expectancy, awareness, and diagnostic facilities. This article aims to highlight this institute’s experience in diagnosis and treatment of patients of multiple primary malignancies and a comprehensive review of literature. Materials and Methods: This is a descriptive study of retrospectively collected data of a single institution over 4 years from 2013 to 2016. Known cases of cancer who were diagnosed with a second primary malignancy were included in the study. Various details such as age, sex, site of disease, temporal relation of two cancers (synchronous or metachronous), family history, tobacco use, treatment given, and survival at 1 year were recorded, organized in a tabular form, analyzed, and described. Results: A total of 29 cases of dual malignancies comprising 0.74% of a total of 3879 patients of cancer were encountered. Seventy-two percent of the cases were metachronous and 5 years was the mean time interval between tumors. There was a female preponderance, and the average age was 56 years. Breast was the most common site of malignancy. At 1 year from diagnosis of second primary, 69% of the patients were alive and 27% were disease-free. Conclusion: Second primary in a patient of cancer is becoming increasingly common and the suspicion of the same should always be borne in mind during follow-up. Prognosis as well as intent of treatment depends on respective stages of the two malignancies.

Keywords

Dual malignancy - metachronous - synchronous

Publikationsverlauf

Eingereicht: 25. März 2018

Angenommen: 21. Juni 2018

Artikel online veröffentlicht:
03. Juni 2021

• References

• 1 Noh SK, Yoon JY, Ryoo UN, Choi CH, Sung CO, Kim TJ. et al. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol 2008; 19: 265-9
• 2 Lee JS, Moon W, Park SJ, Park MI, Kim KJ, Jang LL. et al. Triple synchronous primary cancers of rectum, thyroid, and uterine cervix detected during the workup for hematochezia. Intern Med 2010; 49: 1745-7
• 3 Billroth T. General Surgical Pathology and Therapy in 51 Lectures: A Handbook for Students and Physicians. 14th ed. Berlin, Germany: G. Reimer; 1889: 908
• 4 Owen LJ. Multiple malignant neoplasms. JAMA 1921; 76: 1329-33
• 5 Warren S. Multiple malignant tumours. A survey of the literature and statistical study. Am J Cancer 1932; 16: 1358-414
• 6 Moertel CG. Multiple primary malignant neoplasms: Historical perspectives. Cancer 1977; 40: 1786-92
• 7 Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. Cancer 1961; 14: 221-30
• 8 Sharma D, Singh G, Kakkar N, Raj S. Second primary malignancy: A retrospective analysis report from a tertiary cancer center of North India. Indian J Cancer 2016; 53: 595-9
• 9 Bagri PK, Singh D, Singhal MK, Singh G, Mathur G, Jakhar SL. et al. Double primary malignancies: A clinical & pathological analysis report from a regional cancer institute in India. Iran J Cancer Prev 2014; 7: 66-72
• 10 Jena A, Patnayak R, Lakshmi AY, Manilal B, Reddy MK. Multiple primary cancers: An enigma. South Asian J Cancer 2016; 5: 29-32
• 11 Amer MH. Multiple neoplasms, single primaries, and patient survival. Cancer Manag Res 2014; 6: 119-34
• 12 Bajdik CD, Abanto ZU, Spinelli JJ, Brooks-Wilson A, Gallagher RP. Identifying related cancer types based on their incidence among people with multiple cancers. Emerg Themes Epidemiol 2006; 3: 17
• 13 Gaskin HS, Hardy RE, Fletcher RL. Multiple primary malignancies in black patients. J Natl Med Assoc 1981; 73: 1065-8
• 14 Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L. et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016; 122: 3075-86
• 15 AIRTUM Working Group. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 2010; 34: 1-88
• 16 Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC. et al. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet 2003; 11: 611-8
• 17 Curtis RE, Freedman DM, Ron E, Ries LA, Hacker DG, Edwards BK. et al. editors New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute; 2006: 9-14
• 18 Hall EJ. Radiobiology for the Radiologist. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000: 149
• 19 Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Davies C, Godwin J, Gray R, Clarke M, Cutter D. et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet 2011; 378: 771-84
• 20 Hajdu SI, Hajdu EO. Multiple primary malignant tumors. J Am Geriatr Soc 1968; 16: 16-26
• 21 Berge T, Cederqvist L, Schönebeck J. Multiple primary malignant tumours. An autopsy study of a circumscribed population. Acta Pathol Microbiol Scand 1969; 76: 171-83
• 22 Vyas JJ, Deshpande RK, Sharma S, Desai PB. Multiple primary cancers in Indian population: Metachronous and synchronous lesions. J Surg Oncol 1983; 23: 239-49
• 23 Gursel B, Meydan D, Özbek N, Ozdemir O, Odabas E. Multiple primary malignant neoplasms from the black sea region of turkey. J Int Med Res 2011; 39: 667-74
• 24 Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. et al. Multiple primary cancer: An experience at the cancer institute hospital with special reference to colorectal cancer. Int J Clin Oncol 2003; 8: 162-7
• 25 Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P. et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74: 1933-8
• 26 Lv M, Zhang X, Shen Y, Wang F, Yang J, Wang B. et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore) 2017; 96: e6799
• 27 Mehdi I, Shah AH, Moona MS, Verma K, Abussa A, Elramih R. et al. Synchronous and metachronous malignant tumours expect the unexpected. J Pak Med Assoc 2010; 60: 905-9
• 28 Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 2007; 12: 20-37
• 29 Three Year Report of Population Based and Hospital Based Cancer Registries; 2012-2014. Available from: http://www.ncdirindia.org/. [Last accessed on 2016 May 22]
• 30 Escobar PA, Smith MT, Vasishta A, Hubbard AE, Zhang L. Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FISH). Mutagenesis 2007; 22: 321-7
• 31 Horii A, Han HJ, Shimada M, Yanagisawa A, Kato Y, Ohta H. et al. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res 1994; 54: 3373-5
• 32 European Academies Science Advisory Council. Direct-To-Consumer Genetic Testing for Health-Related Purposes in the European Union: the View from EASAC and FEAM EASAC policy Report. European Academies Science Advisory Council; 2012. p. 18
• 33 Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010; 28: 893-901
• 34 Kelsey JL. Breast and Gynecology Cancer Epidemiology. Boca Raton, FL: CRC Press; 1983
• 35 Brinton LA, Blot WJ, Becker JA, Winn DM, Browder JP, Farmer Jr. JC. et al. A case-control study of cancers of the nasal cavity and paranasal sinuses. Am J Epidemiol 1984; 119: 896-906
• 36 Office on Smoking and Health. Report of the Surgeon General. DHEW Publication No. (PHS) 79-50066. Washington, DC: U.S. Government, Printing Office; 1979
• 37 Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-8
• 38 Liu YY, Chen YM, Yen SH, Tsai CM, Perng RP. Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis. Lung Cancer 2002; 35: 189-94
• 39 Weichert KA, Schumrick D. Multiple malignancies in patients with primary carcinomas of the head and neck. Laryngoscope 1979; 89: 988-91
• 40 Tucker MA, Murray N, Shaw EG, Ettinger DS, Mabry M, Huber MH. et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung cancer working cadre. J Natl Cancer Inst 1997; 89: 1782-8
• 41 Vogel VG. Identifying and screening patients at risk of second cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 2027-32